HomeCompareELRFF vs JNJ

ELRFF vs JNJ: Dividend Comparison 2026

ELRFF yields 666.67% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ELRFF wins by $608115.63M in total portfolio value
10 years
ELRFF
ELRFF
● Live price
666.67%
Share price
$0.30
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$608115.66M
Annual income
$469,561,018,816.25
Full ELRFF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — ELRFF vs JNJ

📍 ELRFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodELRFFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ELRFF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ELRFF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ELRFF
Annual income on $10K today (after 15% tax)
$56,666.67/yr
After 10yr DRIP, annual income (after tax)
$399,126,865,993.81/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, ELRFF beats the other by $399,126,862,007.82/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ELRFF + JNJ for your $10,000?

ELRFF: 50%JNJ: 50%
100% JNJ50/50100% ELRFF
Portfolio after 10yr
$304057.84M
Annual income
$234,780,511,752.82/yr
Blended yield
77.22%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ELRFF
No analyst data
Altman Z
-7.1
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ELRFF buys
0
JNJ buys
0
No recent congressional trades found for ELRFF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricELRFFJNJ
Forward yield666.67%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$608115.66M$30.3K
Annual income after 10y$469,561,018,816.25$4,689.40
Total dividends collected$596792.85M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ELRFF vs JNJ ($10,000, DRIP)

YearELRFF PortfolioELRFF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$77,367$66,666.67$10,592$272.30+$66.8KELRFF
2$564,818$482,035.31$11,289$357.73+$553.5KELRFF
3$3,893,246$3,288,890.67$12,123$472.89+$3.88MELRFF
4$25,352,760$21,186,987.16$13,141$629.86+$25.34MELRFF
5$156,070,781$128,943,327.59$14,408$846.81+$156.06MELRFF
6$908,837,800$741,842,064.29$16,021$1,151.60+$908.82MELRFF
7$5,009,769,782$4,037,313,336.56$18,122$1,588.22+$5009.75MELRFF
8$26,159,339,258$20,798,885,591.56$20,930$2,228.20+$26159.32MELRFF
9$129,490,317,125$101,499,824,118.87$24,792$3,191.91+$129490.29MELRFF
10$608,115,658,140$469,561,018,816.25$30,274$4,689.40+$608115.63MELRFF

ELRFF vs JNJ: Complete Analysis 2026

ELRFFStock

Eastern Platinum Limited, together with its subsidiaries, engages in the mining, exploration, and development of platinum group metal (PGM) and chrome properties in South Africa. Its PGM deposits include platinum, palladium, rhodium, osmium, iridium, and ruthenium. The company principally holds 87.5% interest in the Crocodile River Mine located on the western limb and the Kennedy's Vale project on the eastern limb of Bushveld Complex (BCX); 87% interest in the Mareesburg project situated on the eastern limb of the BCX; and 93.4% interest in the Spitzkop project located on the eastern limb of the BCX. Eastern Platinum Limited is headquartered in Vancouver, Canada.

Full ELRFF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ELRFF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ELRFF vs SCHDELRFF vs JEPIELRFF vs OELRFF vs KOELRFF vs MAINELRFF vs ABBVELRFF vs MRKELRFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.